Citi says sell tgt under $80, page-29

The market may have been expecting more but the below numbers are very impressive.
And the downside was what, that full year will only be 10% growth on last year not 12%.
Well wah wah wah, most companies would be ecstatic with these results.

I expect the Novartis purchase to perform well in coming years.
Continuing buy back
Massive RnD budget and proven results.

Bottom drawer for sure.



"

• Revenues from continuing operations up 5.6% to US$2.8 billion.
• Net profit after tax for the period attributable to members up 7.2% to US$692.2 million. Constant Currency 1
• Sales revenue at constant currency up 8.3% to US$2.8 billion.
• Net profit after tax for the period at constant currency up 9.1% to US$705.0 million.

Dividends

Interim dividend (determined subsequent to balance date) 58.0¢ Unfranked - up almost 10%
Interim dividend from the previous corresponding period 53.0¢ Unfranked
Final dividend (prior year) 60.o¢ Unfranked"